{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-06-24",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Bridgewater",
      "state": "NJ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {
        "application_number": [
          "ANDA206174"
        ],
        "brand_name": [
          "ARIPIPRAZOLE"
        ],
        "generic_name": [
          "ARIPIPRAZOLE"
        ],
        "manufacturer_name": [
          "Ajanta Pharma USA Inc."
        ],
        "product_ndc": [
          "27241-051",
          "27241-052",
          "27241-053",
          "27241-054",
          "27241-055",
          "27241-056"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "ARIPIPRAZOLE"
        ],
        "rxcui": [
          "349490",
          "349545",
          "349547",
          "349553",
          "402131",
          "602964"
        ],
        "spl_id": [
          "2a724a23-cf45-4d22-90f5-ebe68f9b7ab9"
        ],
        "spl_set_id": [
          "d0f910b5-adef-4a93-9369-70f1ed541503"
        ],
        "package_ndc": [
          "27241-051-03",
          "27241-051-08",
          "27241-052-03",
          "27241-052-08",
          "27241-053-03",
          "27241-053-08",
          "27241-054-03",
          "27241-054-08",
          "27241-055-03",
          "27241-055-08",
          "27241-056-03",
          "27241-056-08"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0327241051036",
          "0327241055034",
          "0327241053030",
          "0327241056031",
          "0327241054037",
          "0327241052033"
        ],
        "nui": [
          "N0000175430"
        ],
        "pharm_class_epc": [
          "Atypical Antipsychotic [EPC]"
        ],
        "unii": [
          "82VFR53I78"
        ]
      },
      "product_type": "Drugs",
      "event_id": "99046",
      "recalling_firm": "Ajanta Pharma USA Inc",
      "address_1": "400 Crossing Blvd Ste 102",
      "address_2": "",
      "postal_code": "08807-2863",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "U.S. Nationwide",
      "recall_number": "D-0594-2026",
      "product_description": "Aripiprazole Tablets USP, Rx only, 30 mg, 30 tablets, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India, NDC 27241-056-03.",
      "product_quantity": "6,143 bottles",
      "reason_for_recall": "Product Mix-Up:  A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg.",
      "recall_initiation_date": "20260527",
      "center_classification_date": "20260616",
      "report_date": "20260624",
      "code_info": "Lot: PA00805, expires: 01/31/2029",
      "more_code_info": ""
    }
  ]
}